Subscribe for occasional updates!
Paris, 9 January 2023 – Movianto, Europe’s leading pharmaceutical distributor, is delighted to announce the appointment of Nicolas Virmoux to the management team of its French subsidiary. Nicolas Virmoux will take on the role of Customer Experience Director, a newly created position with the aim of reinforcing customer focus and satisfaction within Movianto France. The main objectives of this new role include improving the customer journey and quality at every stage, developing innovative solutions to meet the specific needs of each customer, and consolidating Movianto’s European approach in terms of solutions and support.
“The creation of the position of Customer Experience Director comes in a context of rapid growth in our business, increasing complexity of the supply chain and ever greater specialisation on the part of our laboratory customers. I am very pleased to be entrusting this mission to Nicolas Virmoux, who, in addition to his enthusiasm and commitment, will bring his market expertise and a fresh perspective to our organisation,” says Nicolas Richer, President of Movianto in France.
With his international background and responsibilities in Sales, Operations and, more recently, in General Management, Nicolas Virmoux has demonstrated his ability to understand and anticipate changes in the distribution of medicines and medical devices in France and Europe. His experience in managing the Covid-19 crisis has also given him an in-depth understanding of the management of strategic stocks for health authorities.
“I’m thrilled to be embarking on this new journey and to be contributing to the next stages in the development of Movianto, our customers and, more broadly, the healthcare industry. The sector is evolving, and we are at our customers’ side to support them through these transitions. I would like to express my gratitude to Nicolas Richer, President of Movianto in France, and Stéphane Baudry, CEO & Chairman of the Walden Group, for the trust they have placed in me,” added Nicolas Virmoux.
About Movianto :
Movianto, a Walden Group entity, is the European leader in logistics and distribution solutions for the pharmaceutical and healthcare industries. Present in France since 1951, historically known as Centre Spécialités Pharmaceutique (CSP), the company merged its operations with Movianto, acquired by Walden from Owens and Minor in 2020. The group offers tailored solutions on a European scale for the entire healthcare industry, including pharmaceuticals, medical devices, diagnostics, biotechnology, etc. Movianto operates the largest healthcare logistics capacity in Europe, with 600,000m² of warehousing space and more than 3,000 employees in 13 countries. Movianto’s unique proposition lies in its ability to address the entire supply chain for healthcare products through a broad service offering supported by local teams of experts and European coordination.
For media enquiries, please contact:
TEAM LEWIS Agency
Romain MICHAUD / Leyla BUYEL
Tel : 06 17 98 29 88 / 07 68 16 08 17
For more information, please contact:
Laure Murat | Marketing and Communication at Walden Group
Movianto in France is opening its first centre of innovation and excellence on its Moussy-le-Neuf campus near Roissy Charles de Gaulle airpo...
9th February 2024
Movianto Nordic started transferring clients to their recently completed pharma logistics hub in Køge earlier this month.
10th November 2023
Movianto was approached by a leading medical technology company that needed to upgrade their separate Czech and Slovak logistics solutions i...
30th March 2023
A global pharmaceutical manufacturer was experiencing supply chain issues due to the coronavirus. Movianto found a solution based on repacka...
28th March 2023
Terms and Conditions